US · Healthcare

Anixa Biosciences Inc (ANIX)

Biotechnology

Anixa Biosciences Inc (ANIX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ANIX

P/E ratio

25.00

Anixa Biosciences Inc (ANIX) — FAQ

What is ANIX's P/E ratio?

The price-to-earnings (P/E) ratio for Anixa Biosciences Inc (ANIX) is 25.00 (data as of 2026-05-23).

Does Anixa Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Anixa Biosciences Inc (ANIX). Check the MyAverix Finance app for the latest dividend data.

What sector is Anixa Biosciences Inc in?

Anixa Biosciences Inc (ANIX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ANIX listed on?

ANIX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)